Serum Sclerostin Levels Are Increased According to the Progression of Nephropathy in Type 2 Diabetes Subjects

被引：0
|
作者：
Aoki, Atsushi [1 ]
机构：
[1] Jichi Med Univ, Saitama Med Ctr, Saitama, Japan
来源：
ENDOCRINE REVIEWS | 2014年 / 35卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
MON-1015
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Proinsulin levels are significantly increased both in type 1 and type 2 diabetes compared with normal subjects
    Ionescu-Tirgoviste, Constantin
    Guja, Cristian
    Vladica, Maria
    Ioacara, Sorin
    Bojin, Andrada
    Filip, Iulia
    DIABETES, 2006, 55 : A573 - A573
  • [32] Serum levels of sFas and sFasL in subjects with type 2 diabetes - the impact of arterial hypertension
    Stoynev, Nikolay
    Kalinov, Krassimir
    Kirilov, Georgi
    Tankova, Tsvetalina
    CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2014, 9 (05): : 704 - 708
  • [33] Is TGFβ1 serum levels a risk marker for nephropathy in patients with Type 2 diabetes mellitus?
    Pou, J
    de Prado, A
    Ortiz, A
    Gallo, G
    Martinez, E
    Martinez, J
    Cubero, J
    Ybarra, J
    Doñate, T
    DIABETOLOGIA, 2002, 45 : A353 - A353
  • [34] Elevated Serum Levels of Mannose-Binding Lectin and Diabetic Nephropathy in Type 2 Diabetes
    Guan, Ling-Zhi
    Tong, Qiang
    Xu, Jing
    PLOS ONE, 2015, 10 (03):
  • [35] Serum lipoprotein(a) levels and diabetic nephropathy among Japanese patients with type 2 diabetes mellitus
    Senba, Hidenori
    Furukawa, Shinya
    Sakai, Takenori
    Niiya, Tetsuji
    Miyake, Teruki
    Yamamoto, Shin
    Ueda, Teruhisa
    Torisu, Masamoto
    Minami, Hisaka
    Miyaoka, Hiroaki
    Onji, Morikazu
    Tanaka, Keiko
    Matsuura, Bunzo
    Tanigawa, Takeshi
    Hiasa, Yoichi
    Miyake, Yoshihiro
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (05) : 923 - 927
  • [36] Salivary and serum cystatin SA levels in patients with type 2 diabetes mellitus or diabetic nephropathy
    Techatanawat, Suteera
    Surarit, Rudee
    Chairatvit, Kongthawat
    Roytrakul, Sittiruk
    Khovidhunkit, Weerapan
    Thanakun, Supanee
    Izumi, Yuichi
    Khovidhunkit, Siribang-on Piboonniyom
    ARCHIVES OF ORAL BIOLOGY, 2019, 104 : 67 - 75
  • [37] Serum Levels of Lipoprotein(a) and Diabetic Nephropathy among Japanese Patients with Type 2 Diabetes Mellitus
    Senba, Hidenori
    Furukawa, Shinya
    Sakai, Takenori
    Niiya, Tetsuji
    Miyake, Teruki
    Yamamoto, Shin
    Ueda, Teruhisa
    Ueda, Teruhisa
    Torisu, Masamoto
    Minami, Hisaka
    Miyaoka, Hiroaki
    Onji, Morikazu
    Tanaka, Keiko
    Matsuura, Bunzo
    Hiasa, Yoichi
    Tanigawa, Takeshi
    Miyake, Yoshihiro
    DIABETES, 2016, 65 : A145 - A146
  • [38] Type 2 diabetes raises serum sclerostin levels and disturbs the relation between sclerostin and bone mineral density: a call for caution with antisclerostin therapy in osteoporosis
    Dina S. Al-Zifzaf
    Sarah A. Hamza
    Eman A. Kaddah
    Rania A. Abo-Shady
    Egyptian Rheumatology and Rehabilitation, 2014, 41 (1) : 37 - 43
  • [39] Serum Ceruloplasmin Level as a Predictor for the Progression of Diabetic Nephropathy in Korean Men with Type 2 Diabetes Mellitus
    Lee, Min Jung
    Jung, Chang Hee
    Kang, Yu Mi
    Jang, Jung Eun
    Leem, Jaechan
    Park, Joong-Yeol
    Lee, Woo Je
    DIABETES & METABOLISM JOURNAL, 2015, 39 (03) : 230 - 239
  • [40] Increased levels of serum adenosine deaminase and increased risk of diabetic peripheral neuropathy in type 2 diabetes
    Yu, Chao
    Zhuang, Lei
    Xu, Feng
    Zhao, Li-hua
    Wang, Xiao-hua
    Wang, Chun-hua
    Ning, Li-yan
    Zhang, Xiu-lin
    Zhang, Dong-mei
    Wang, Xue-qin
    Su, Jian-bin
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
12345